| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.785 | 0.004 | 0.785 | Cardiotonic | 0.761 0.005 CID_154700129 | ||
| 0.686 | 0.005 | 0.686 | Potassium channel blocker | 0.647 0.005 CID_154700129 | ||
| 0.675 | 0.004 | 0.681 | Bronchodilator | 0.681 0.004 CID_154700129 | CID_154700129 | |
| 0.584 | 0.007 | 0.584 | Vasodilator | 0.584 0.007 CID_154700129 | ||
| 0.521 | 0.026 | 0.544 | Angiogenesis inhibitor | 0.544 0.023 CID_154700129 | CID_154700129 | |
| 0.452 | 0.026 | 0.488 | Antioxidant | 0.488 0.021 CID_154700129 | CID_154700129 | |
| 0.359 | 0.004 | 0.359 | Potassium channel activator | 0.297 0.004 CID_154700129 | ||
| 0.157 | 0.017 | 0.157 | Platelet growth factor antagonist | 0.141 0.022 CID_154700129 | ||
| 0.199 | 0.095 | 0.553 | Hypolipemic | 0.177 0.112 CID_154700129 0.553 0.009 CID_11299037 | CID_11299037 | |
| 0.107 | 0.016 | 0.107 | Potassium channel Kv1.5 blocker | 0.085 0.023 CID_154700129 | ||
| 0.164 | 0.077 | 0.389 | Catenin beta inhibitor | 0.143 0.124 CID_154700129 0.389 0.004 CID_11299037 | CID_11299037 | |
| 0.085 | 0.009 | 0.105 | Acetyl-CoA transferase 2 inhibitor | 0.08 0.011 CID_154700129 0.105 0.005 CID_11299037 | CID_11299037 | |
| 0.083 | 0.007 | 0.083 | Potassium channel (Inward rectifier) activator | 0.055 0.026 CID_154700129 | ||
| 0.08 | 0.007 | 0.08 | Potassium channel (ATP-sensitive) activator | 0.053 0.025 CID_154700129 | ||
| 0.256 | 0.207 | 0.347 | Cyclophilin D inhibitor | 0.263 0.199 CID_154700129 0.347 0.125 CID_11299037 | CID_11299037 | |
| 0.046 | 0.022 | 0.091 | Acetyl-CoA transferase 1 inhibitor | 0.04 0.03 CID_154700129 0.091 0.005 CID_11299037 | CID_11299037 | |
| 0.093 | 0.071 | 0.093 | Chemokine receptor antagonist | 0.085 0.08 CID_154700129 | ||
| 0.14 | 0.121 | 0.14 | Lipocortins synthesis antagonist | |||
| 0.056 | 0.043 | 0.056 | Fibroblast growth factor 4 antagonist | |||
| 0.049 | 0.043 | 0.133 | Acetyl-CoA transferase inhibitor | 0.133 0.007 CID_11299037 | CID_11299037 | |
| 0.061 | 0.059 | 0.061 | Potassium channel (ATP-sensitive) blocker | |||
| 0.015 | 0.045 | 0.191 | Bradykinin B1 receptor antagonist | 0.191 0.004 CID_11299037 | CID_11299037 | |
| 0.066 | 0.132 | 0.117 | Vanilloid agonist | 0.117 0.02 CID_11299037 | CID_11299037 | |
| 0.015 | 0.091 | 0.123 | Potassium channel subfamily K member 3 blocker | 0.123 0.004 CID_11299037 | CID_11299037 | |
| 0.011 | 0.098 | 0.134 | Bradykinin antagonist | 0.134 0.005 CID_11299037 | CID_11299037 | |
| 0.009 | 0.107 | 0.053 | Leukotriene D4 antagonist | 0.053 0.009 CID_11299037 | CID_11299037 | |
| 0.009 | 0.125 | 0.149 | AMPA 2 receptor antagonist | 0.149 0.004 CID_11299037 | CID_11299037 | |
| 0.009 | 0.172 | 0.037 | AMPA receptor agonist | 0.037 0.021 CID_11299037 | CID_11299037 | |
| 0.042 | 0.215 | 0.092 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.056 CID_11299037 | CID_11299037 | |
| 0.004 | 0.186 | 0.077 | Growth hormone secretagogue receptor agonist | 0.077 0.012 CID_11299037 | CID_11299037 | |
| 0.006 | 0.213 | 0.023 | Kainate receptor 4 antagonist | 0.023 0.019 CID_11299037 | CID_11299037 | |
| 0.015 | 0.226 | 0.09 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.09 0.017 CID_11299037 | CID_11299037 | |
| 0.005 | 0.229 | 0.02 | Kainate receptor 5 antagonist | 0.02 0.015 CID_11299037 | CID_11299037 | |
| 0.008 | 0.253 | 0.053 | Cholesterol ester transfer protein antagonist | 0.053 0.006 CID_11299037 | CID_11299037 | |
| 0.005 | 0.266 | 0.075 | Protease activated receptor 1 antagonist | 0.075 0.021 CID_11299037 | CID_11299037 | |
| 0.007 | 0.285 | 0.13 | MAP3K8 inhibitor | 0.13 0.002 CID_11299037 | CID_11299037 | |
| 0.107 | 0.406 | 0.385 | Analgesic | 0.385 0.091 CID_11299037 | CID_11299037 | |
| 0.034 | 0.344 | 0.095 | Falcipain 2 inhibitor | 0.095 0.056 CID_11299037 | CID_11299037 | |
| 0.034 | 0.35 | 0.095 | Falcipain inhibitor | 0.095 0.058 CID_11299037 | CID_11299037 | |
| 0.005 | 0.349 | 0.12 | NMDA receptor subunit 3A antagonist | 0.12 0.007 CID_11299037 | CID_11299037 | |
| 0.008 | 0.396 | 0.057 | Leukotriene antagonist | 0.057 0.055 CID_11299037 | CID_11299037 | |
| 0.003 | 0.409 | 0.077 | Kainate receptor antagonist | 0.077 0.01 CID_11299037 | CID_11299037 | |
| 0.031 | 0.45 | 0.122 | Acetylcholine release stimulant | 0.122 0.046 CID_11299037 | CID_11299037 | |
| 0.011 | 0.449 | 0.344 | MAP kinase kinase kinase inhibitor | 0.344 0.004 CID_11299037 | CID_11299037 | |
| 0.081 | 0.553 | 0.181 | MAP kinase kinase 5 inhibitor | 0.181 0.061 CID_11299037 | CID_11299037 | |
| 0.006 | 0.484 | 0.066 | Glutamate (mGluR) agonist | 0.066 0.04 CID_11299037 | CID_11299037 | |
| 0.023 | 0.516 | 0.139 | Acetylcholine M1 receptor antagonist | 0.139 0.085 CID_11299037 | CID_11299037 | |
| 0.005 | 0.509 | 0.061 | Acetylcholine muscarinic agonist | 0.061 0.033 CID_11299037 | CID_11299037 | |
| 0.003 | 0.517 | 0.053 | Acetylcholine M1 receptor agonist | 0.053 0.024 CID_11299037 | CID_11299037 | |
| 0.065 | 0.585 | 0.149 | Cyclin-dependent kinase 3 inhibitor | 0.149 0.099 CID_11299037 | CID_11299037 | |
| 0.007 | 0.559 | 0.07 | Protein kinase C alpha inhibitor | 0.07 0.044 CID_11299037 | CID_11299037 | |
| 0.002 | 0.566 | 0.033 | 5 Hydroxytryptamine 3B antagonist | 0.033 0.029 CID_11299037 | CID_11299037 | |
| 0.013 | 0.578 | 0.091 | Transforming growth factor antagonist | 0.091 0.026 CID_11299037 | CID_11299037 | |
| 0.003 | 0.568 | 0.112 | AMPA 3 receptor antagonist | 0.112 0.004 CID_11299037 | CID_11299037 | |
| 0.008 | 0.574 | 0.072 | Acetylcholine M4 receptor antagonist | 0.072 0.055 CID_11299037 | CID_11299037 | |
| 0 | 0.573 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 CID_11299037 | CID_11299037 | |
| 0.022 | 0.596 | 0.101 | TRPA1 agonist | 0.101 0.086 CID_11299037 | CID_11299037 | |
| 0.005 | 0.585 | 0.055 | AMPA 4 receptor antagonist | 0.055 0.012 CID_11299037 | CID_11299037 | |
| 0.005 | 0.585 | 0.13 | MAO inhibitor | 0.13 0.069 CID_11299037 | CID_11299037 | |
| 0.01 | 0.593 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.033 CID_11299037 | CID_11299037 | |
| 0.002 | 0.59 | 0.047 | Glutamate (mGluR1a) agonist | 0.047 0.005 CID_11299037 | CID_11299037 | |
| 0.008 | 0.618 | 0.127 | CDC-like kinase 2 inhibitor | 0.127 0.112 CID_11299037 | CID_11299037 | |
| 0.001 | 0.627 | 0.035 | Kainate receptor 1 antagonist | 0.035 0.008 CID_11299037 | CID_11299037 | |
| 0.009 | 0.641 | 0.119 | Potassium channel (Tandem pore domain) blocker | 0.119 0.005 CID_11299037 | CID_11299037 | |
| 0.005 | 0.643 | 0.062 | Acetylcholine M5 receptor antagonist | 0.062 0.039 CID_11299037 | CID_11299037 | |
| 0.046 | 0.703 | 0.284 | 5 Hydroxytryptamine release inhibitor | 0.284 0.184 CID_11299037 | CID_11299037 | |
| 0.004 | 0.665 | 0.054 | CC chemokine 2 receptor antagonist | 0.054 0.038 CID_11299037 | CID_11299037 | |
| 0.002 | 0.666 | 0.152 | Oleamide hydrolase inhibitor | 0.152 0.005 CID_11299037 | CID_11299037 | |
| 0.004 | 0.672 | 0.09 | Cannabinoid CB1 receptor antagonist | 0.09 0.02 CID_11299037 | CID_11299037 | |
| 0.016 | 0.684 | 0.097 | HIV-1 integrase (Overall Integration) inhibitor | 0.097 0.057 CID_11299037 | CID_11299037 | |
| 0.001 | 0.676 | 0.124 | AMPA 1 receptor antagonist | 0.124 0.005 CID_11299037 | CID_11299037 | |
| 0.005 | 0.683 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 CID_11299037 | CID_11299037 | |
| 0.003 | 0.681 | 0.085 | MAO B inhibitor | 0.085 0.071 CID_11299037 | CID_11299037 | |
| 0.017 | 0.697 | 0.181 | Alpha 1b adrenoreceptor agonist | 0.181 0.003 CID_11299037 | CID_11299037 | |
| 0.006 | 0.697 | 0.06 | NMDA receptor agonist | 0.06 0.047 CID_11299037 | CID_11299037 | |
| 0.008 | 0.72 | 0.224 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.224 0.087 CID_11299037 | CID_11299037 | |
| 0.003 | 0.72 | 0.055 | NMDA receptor glycine site agonist | 0.055 0.051 CID_11299037 | CID_11299037 | |
| 0.004 | 0.723 | 0.083 | Acetylcholine agonist | 0.083 0.063 CID_11299037 | CID_11299037 | |
| 0.004 | 0.722 | 0.087 | Cannabinoid receptor antagonist | 0.087 0.035 CID_11299037 | CID_11299037 | |
| 0.003 | 0.724 | 0.049 | CC chemokine 3 receptor antagonist | 0.049 0.024 CID_11299037 | CID_11299037 | |
| 0.003 | 0.731 | 0.052 | Glutamate (mGluR group I) agonist | 0.052 0.029 CID_11299037 | CID_11299037 | |
| 0.002 | 0.759 | 0.079 | AMPA receptor antagonist | 0.079 0.018 CID_11299037 | CID_11299037 | |
| 0.005 | 0.763 | 0.145 | Glutamate receptor antagonist | 0.145 0.055 CID_11299037 | CID_11299037 | |
| 0.029 | 0.791 | 0.367 | GABA C receptor rho-3 antagonist | 0.367 0.077 CID_11299037 | CID_11299037 | |
| 0.014 | 0.782 | 0.222 | Antiobesity | 0.222 0.185 CID_11299037 | CID_11299037 | |
| 0.007 | 0.775 | 0.054 | Glutamate (mGluR4) antagonist | 0.054 0.017 CID_11299037 | CID_11299037 | |
| 0.002 | 0.774 | 0.047 | Calcium release-activated channel blocker | 0.047 0.011 CID_11299037 | CID_11299037 | |
| 0.003 | 0.784 | 0.074 | NMDA receptor antagonist | 0.074 0.073 CID_11299037 | CID_11299037 | |
| 0.003 | 0.794 | 0.117 | Glutamate receptor agonist | 0.117 0.028 CID_11299037 | CID_11299037 | |
| 0.001 | 0.811 | 0.027 | Alpha 2a adrenoreceptor agonist | 0.027 0.006 CID_11299037 | CID_11299037 | |
| 0.003 | 0.816 | 0.112 | Amidase inhibitor | 0.112 0.019 CID_11299037 | CID_11299037 | |
| 0.009 | 0.827 | 0.093 | Electrolyte absorption antagonist | 0.093 0.068 CID_11299037 | CID_11299037 | |
| 0.006 | 0.825 | 0.107 | 5 Hydroxytryptamine 3A agonist | 0.107 0.068 CID_11299037 | CID_11299037 | |
| 0.009 | 0.836 | 0.195 | Hemostatic | 0.195 0.034 CID_11299037 | CID_11299037 | |
| 0.003 | 0.842 | 0.084 | Alpha 1a adrenoreceptor agonist | 0.084 0.004 CID_11299037 | CID_11299037 | |
| 0.005 | 0.855 | 0.263 | DNA polymerase beta inhibitor | 0.263 0.185 CID_11299037 | CID_11299037 | |
| 0.005 | 0.867 | 0.239 | DNA directed DNA polymerase inhibitor | 0.239 0.198 CID_11299037 | CID_11299037 | |
| 0.003 | 0.883 | 0.124 | Sphingosine 1-phosphate receptor 2 antagonist | 0.124 0.087 CID_11299037 | CID_11299037 | |
| 0.003 | 0.888 | 0.253 | Ferrochelatase inhibitor | 0.253 0.013 CID_11299037 | CID_11299037 | |
| 0.006 | 0.903 | 0.24 | Transcription factor inhibitor | 0.24 0.194 CID_11299037 | CID_11299037 | |
| 0.001 | 0.9 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 CID_11299037 | CID_11299037 | |
| 0.002 | 0.904 | 0.06 | TRPA1 antagonist | 0.06 0.043 CID_11299037 | CID_11299037 | |
| 0.022 | 0.945 | 0.294 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.294 0.221 CID_11299037 | CID_11299037 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |